Search Results - "Stilgenbauer, Linda"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Evaluation of a targeted prodrug strategy to enhance oral absorption of poorly water-soluble compounds by CHAN, O. H, SCHMID, H. L, STILGENBAUER, L. A, HOWSON, W, HORWELL, D. C, STEWART, B. H

    Published in Pharmaceutical research (01-07-1998)
    “…The purpose of this research was to examine a targeted prodrug strategy to increase the absorption of a poorly water-soluble lipophilic compound. Three…”
    Get full text
    Journal Article
  3. 3

    Phosphate prodrugs of PD154075 by Zhu, Z, Chen, H G, Goel, O P, Chan, O H, Stilgenbauer, L A, Stewart, B H

    Published in Bioorganic & medicinal chemistry letters (15-05-2000)
    “…In the preparation of phosphate prodrugs of PD154075, several strategies of linking a phosphate group to the indole moiety were studied. A novel linker,…”
    Get full text
    Journal Article
  4. 4

    EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO by SAHI, Jasminder, STERN, Ralph H, LECLUYSE, Edward L, MILAD, Mark A, ROSE, Kelly A, GIBSON, Gordon, XIANXIAN ZHENG, STILGENBAUER, Linda, SADAGOPAN, Nalini, JOLLEY, Summer, GILBERT, Darryl

    Published in Drug metabolism and disposition (01-12-2004)
    “…Avasimibe, an acyl-CoA:cholesterol acyltransferase inhibitor, has been previously shown to be a potent inducer of CYP3A4 and multiple drug resistance protein…”
    Get full text
    Journal Article